{
    "Case ID": "091396",
    "Different Crime": [
        {
            "Crime Name": "Patent Infringement",
            "Crime Type": "Economic_Crimes_or_Fraud-related_Offenses",
            "legal_basis": [
                "Patented Medicines (Notice of Compliance) Regulations"
            ],
            "decision_outcome": [
                "Prohibition order granted"
            ],
            "procedural_fairness": [
                "Judicial review application under s. 6(1) of the Regulations"
            ],
            "expert_testimony": [
                "Evidence from both parties' experts was evaluated"
            ],
            "patent_validity": [
                "Novopharm's allegation unjustified"
            ],
            "technical_details": [
                "Obvious chemical equivalents",
                "Differences in protecting groups and reaction steps"
            ],
            "appeal_outcome": [
                "Novopharm cannot receive Notice of Compliance until after Lilly's patent expires"
            ]
        }
    ]
}